← Back to Search

Laparoscopic Burch Colposuspension for Irritable Bowel Syndrome (MICRO Trial)

N/A
Waitlist Available
Led By Sarah A Collins, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English or Spanish speaking and reading
Symptomatic pelvic organ prolapse with any compartment at or beyond the hymen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks and 3 months following study intervention
Awards & highlights

MICRO Trial Summary

This trial is testing whether adding a Burch colposuspension to a sacrocolpopexy prevents stress urinary incontinence.

Eligible Conditions
  • Irritable Bowel Syndrome
  • Stress Incontinence
  • Sexual Dysfunction
  • Urge Urinary Incontinence
  • Pelvic Organ Prolapse

MICRO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MICRO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks and 3 months following study intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks and 3 months following study intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Urinary Incontinence
Secondary outcome measures
Bowel Symptoms
Pelvic Organ Prolapse
Rate of Surgical Complication
+5 more

MICRO Trial Design

2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Patients in this arm will undergo standard laparoscopic or robotic sacrocolpopexy, without the addition of a laparoscopic/robotic Burch colposuspension
Group II: Laparoscopic Burch ColposuspensionActive Control1 Intervention
Patients in this arm will undergo standard laparoscopic or robotic sacrocolpopexy, with the addition of a laparoscopic/robotic Burch colposuspension

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,576 Previous Clinical Trials
911,868 Total Patients Enrolled
1 Trials studying Irritable Bowel Syndrome
40 Patients Enrolled for Irritable Bowel Syndrome
Friends of PrenticeOTHER
3 Previous Clinical Trials
650 Total Patients Enrolled
Sarah A Collins, MDPrincipal InvestigatorNorthwestern University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~9 spots leftby Mar 2025